Innoviva Statistics
NASDAQ: INVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
21.06+0.23 (+1.10%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Innoviva by the numbers
Innoviva has a market capitalization of $1.52 billion based on 72.25M shares outstanding. Its trailing P/E ratio is 4.9, and its forward P/E is 9.5. The stock trades 0.4% above its 50-day average and 3.3% below its 200-day average.
Average daily trading volume is 822.88K shares, or about $17.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INVA valuation vs. peer median
| Metric | INVA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.52B | $1.50B | +1% |
| Forward P/E | 9.5 | 21.3 | -55% |
| Avg. volume | 822.88K | 486.70K | +69% |
Peer median across 8 companies: SNDX, RAPP, PAHC, RARE, GHRS, STOK, KRSA, ETON.
Valuation
- Market cap
- $1.52B
- P/E (TTM)
- 4.92
- Forward P/E
- 9.53
- EPS (TTM)
- $4.28
- Shares outstanding
- 72.25M
Price and trading
- Previous close
- 20.83
- Open
- 20.78
- Day range
- 20.78 – 21.10
- 52-week range
- 16.52 – 25.15
- 52-week change
- +22.44%
- Beta
- —
- Volume
- 636.35K
- Average volume
- 822.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.52B
- Pe
- 4.92
- Forward Pe
- 9.53
- Eps
- 4.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.15
- Week52 Low
- 16.52
- Avg Volume
- 822.88K
- Shares Outstanding
- 72.25M
- Ma50
- 20.98
- Ma200
- 21.77
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -16.26%
- Pct From52w Low
- 27.48%